"Whilst we understand there is a view from some market observers to initially move to field
trials as opposed to plot and glasshouse trials pundits need to understand that the cost in
doing so is cost prohibitive. The Company takes a conservative view on the trials and
would prefer to focus on good science practices to deliver early results and then
proactively follow these up in conjunction with industry partners on field trials. Whilst this
may add an additional year or so to our testing program it allows the company to
appropriately protect its shareholders and working capital reserves.”
The final harvestable yield of glasshouse grown wheat (at the end of the life cycle) was not measured. Is this "good science practice"?
GPP Price at posting:
2.7¢ Sentiment: None Disclosure: Not Held
